Anders Kronborg, M.Sc.
CHIEF EXECUTIVE OFFICER
Mr Kronborg is a seasoned executive with more than 25 years experience as CEO, CFO or COO. After he graduated as economist from Copenhagen University he spent 7 years in different roles in the ministry of Finance. From 2007-2015 Mr Kronborg worked for Kinnevik – a Swedish investment company listed in Stockholm – from 2012-2015 as COO for the whole group, getting private companies ready to go public and listing them together with other investors.
More recently (2015-2022) Mr Kronborg was CFO and interim CEO in LEO Pharma – a global Pharma company specialized in skin diseases.
Hanne Vissing Leth, M.Sc.
CHIEF FINANCIAL OFFICER
Hanne Vissing Leth is a finance executive with broad experience across disciplines of Finance, Funding, Investor Relations and Corporate Governance.
Hanne’s career has been focused on the Life Science sector and she has held senior leadership positions in both public and private biotech and medtech companies. She has also worked for more than 10 years in investment banking and equity research.
Hanne holds a Master’s degree in Business Administration and International Finance from the Aarhus School of Business and Social Sciences and has a certificate of Board Leadership from Copenhagen Business School Executive.
Morten Lind Jensen, MD, PhD.
CHIEF MEDICAL OFFICER
Morten Lind Jensen has broad experience with clinical product development leadership from positions in both biotech and pharma companies.
Before joining ResoTher, Morten was CMO in Union Therapeutics, a private scale-up biotech company. Prior to that, he spent almost 10 years in Novo Nordisk, spanning roles as medical specialist, project manager and line manager, where he has worked across the internal product portfolio and established external collaboration projects within new ways of doing clinical trials and using data.
Morten is MD with a PhD from University of Copenhagen, Denmark and he holds a Diploma in Pharmaceutical Medicine from the Royal Colleges of Physicians of the United Kingdom.
Mads Bjerregaard, M.Sc.
CHIEF BUSINESS OFFICER
Mads Bjerregaard has throughout his career been pushing clinical pharmaceutical innovations towards partnering and commercialization. He has +20 years of experience, including international, from senior commercial and business development positions in pharma, biotech and medtech companies.
Mads has most recently worked with business leadership in scale-up medtech companies, including UNEEG Medical, and prior to that held leadership positions with Zealand Pharma and Lundbeck.
Mads holds a Master’s degree in Management Accounting and Finance from Copenhagen Business School.
Anders Kronborg, M.Sc. Economics
CHIEF EXECUTIVE OFFICER
Mr Kronborg is a seasoned executive with more than 25 years experience as CEO, CFO or COO. After he graduated as economist from Copenhagen University he spent 7 years in different roles in the ministry of Finance. From 2007-2015 Mr Kronborg worked for Kinnevik – a Swedish investment company listed in Stockholm – from 2012-2015 as COO for the whole group, getting private companies ready to go public and listing them together with other investors.
More recently (2015-2022) Mr Kronborg was CFO and interim CEO in LEO Pharma – a global Pharma company specialized in skin diseases.
Hanne Vissing Leth, M.Sc.
CHIEF FINANCIAL OFFICER
Hanne Vissing Leth is a finance executive with broad experience across disciplines of Finance, Funding, Investor Relations and Corporate Governance.
Hanne’s career has been focused on the Life Science sector and she has held senior leadership positions in both public and private biotech and medtech companies. She has also worked for more than 10 years in investment banking and equity research.
Hanne holds a Master’s degree in Business Administration and International Finance from the Aarhus School of Business and Social Sciences and has a certificate of Board Leadership from Copenhagen Business School Executive.
Morten Lind Jensen
CHIEF MEDICAL OFFICER
Morten Lind Jensen has broad experience with clinical product development leadership from positions in both biotech and pharma companies.
Before joining ResoTher, Morten was CMO in Union Therapeutics, a private scale-up biotech company. Prior to that, he spent almost 10 years in Novo Nordisk, spanning roles as medical specialist, project manager and line manager, where he has worked across the internal product portfolio and established external collaboration projects within new ways of doing clinical trials and using data.
Morten is MD with a PhD from University of Copenhagen, Denmark and he holds a Diploma in Pharmaceutical Medicine from the Royal Colleges of Physicians of the United Kingdom.
Mads Bjerregaard, M.Sc.
CHIEF BUSINESS OFFICER
Mads Bjerregaard has throughout his career been pushing clinical pharmaceutical innovations towards partnering and commercialization. He has +20 years of experience, including international, from senior commercial and business development positions in pharma, biotech and medtech companies.
Mads has most recently worked with business leadership in scale-up medtech companies, including UNEEG Medical, and prior to that held leadership positions with Zealand Pharma and Lundbeck.
Mads holds a Master’s degree in Management Accounting and Finance from Copenhagen Business School.
